3rd Quarter - Report

HELIX, INC. for HELIX, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$36,520
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 3, 2022 $36,520 Replaced
3rd Quarter - Amendment Aug 3, 2023 $130,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Human and Viral Genomic research, testing,funding and insurance coverage, pandemic preparedness, viral surveillance, Lab Developed Tests

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research, Lab Developed Tests

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE; White House Office; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Covid Supplemental for surveillance and testing

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Viral Surveillance, Viral and population genomics

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.